Korea Investment Corp Repligen Corp Transaction History

Korea Investment Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $409,080 - $623,676	3,409 Added 23.47%	17,934 $2.26 Million
Q1 2024 May 14, 2024	SELL	$170.78 - $208.42 $158,996 - $194,039	-931 Reduced 6.02%	14,525 $2.67 Million
Q4 2023 Feb 13, 2024	BUY	$114.17 - $185.35 $179,361 - $291,184	1,571 Added 11.31%	15,456 $2.78 Million
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $89,929 - $114,378	-648 Reduced 4.46%	13,885 $2.21 Million
Q2 2023 Aug 11, 2023	SELL	$138.42 - $180.31 $301,617 - $392,895	-2,179 Reduced 13.04%	14,533 $2.06 Million
Q1 2023 May 12, 2023	SELL	$154.26 - $198.1 $47,820 - $61,411	-310 Reduced 1.82%	16,712 $2.81 Million
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $2.76 Million - $3.75 Million	17,022 New	17,022 $2.88 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Korea Investment Corp with notifications on news.